NCT00384826已完成2 期
Effect of an Early Therapeutic Permutation on the Tumoral Control of Patients Receiving in First Line a Specific Inhibitor of Tyrosin Kinase of EGFR (Erlotinib) or a Taxan-based Chemotherapy for the Treatment of Not Resecable Adenocarcinoma With Bronchiolo-alveolar.
Intergroupe Francophone de Cancerologie Thoracique9 个研究点 分布在 1 个国家目标入组 133 人开始时间: 2006年9月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 133
- 试验地点
- 9
- 主要终点
- 16-week Disease Control Rate
研究概览
简要总结
To evaluate among patients with untreated advanced ADC-CBA, impact on the disease control rate after 4 months treatment of an early therapeutic permutation with the first month in the absence of stabilization or objective answer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •CBA histologically proven (or cytologically with pneumonic presentation) PS < 3 signed and written informed consent
排除标准
- •visible tumoral lesion in bronchial fibroscopy
研究组 & 干预措施
1
Experimental
干预措施: erlotinib (Drug)
2
Experimental
干预措施: paclitaxel + carboplatine (Drug)
结局指标
主要结局
16-week Disease Control Rate
时间窗: 4-week
次要结局
未报告次要终点
研究者
研究点 (9)
Loading locations...
相似试验
已完成
不适用
pfront abiraterone and docetaxel administration in patients with high-risk metastatic hormone-naive prostate cancerMetastatic prostate cancer without initial treatmentJPRN-UMIN000021079Department of Urology, Akita University School of Medicine301
已完成
3 期
Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)Acute Myeloid LeukemiaNCT01382147Prof. Dr. Wolfgang Hiddemann396
终止
1 期
Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy AloneRadiation Therapy, Breast Cancer, Sequential Partial Breast IrradiationIntermediate and High-risk Luminal and Triple Negative Breast CancerNCT02806258University Hospital, Grenoble362
Unknown
3 期
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML PatientsInduction ChemotherapyAcute Myeloid LeukemiaNCT04087967The First Affiliated Hospital of Soochow University162
招募中
不适用
A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.Carcinoma, HepatocellularNCT06205732Qianfoshan Hospital100